Sinofn Health
Sinofn Health
For global brands and nutraceutical formulators, the distinction between CoQ10 (Ubiquinone) and Ubiquinol is not merely semantic; it is a fundamental challenge of bioavailability and chemical stability. At SINOFN, we categorize this within our Advanced Bioavailability R&D Matrix.
The Chemical Reality: Coenzyme Q10 exists in two forms: Ubiquinone (the oxidized form) and Ubiquinol (the reduced form). While the human body can convert Ubiquinone to Ubiquinol, this process becomes significantly less efficient with age, oxidative stress, or metabolic disorders. Ubiquinol is the "active" form responsible for ATP production in mitochondria. Our proprietary manufacturing process utilizes specialized micro-encapsulation techniques to stabilize the oxygen-sensitive Ubiquinol, ensuring that the consumer receives the potent, ready-to-absorb nutrient they expect.
As a leading Chinese manufacturer, SINOFN leverages a unique confluence of factors: high-throughput capacity, rigorous GMP compliance, and an integrated supply chain that spans from raw material extraction to final product packaging. We address the global supply chain volatility by implementing localized redundancy in raw material procurement and utilizing blockchain-verified batch tracking. This ensures that when we produce CoQ10/Ubiquinol-based supplements, the purity and stability are unmatched.
Medical Innovation Director, Peking University Medical School. 15+ years in metabolic disorder formulations.
R&D Lead, CAS Postdoc. Specialist in bioactive compound delivery systems and stability optimization.
Formulation Director (Netherlands). EU regulatory specialist in nutraceutical delivery technology.
Q: Why is Ubiquinol harder to manufacture than CoQ10?
A: Ubiquinol is highly sensitive to oxygen and light. Without proper vacuum encapsulation and moisture-barrier packaging, it reverts to Ubiquinone. SINOFN employs proprietary anaerobic production lines.
Q: How does SINOFN ensure global regulatory compliance?
A: We operate under ISO22000, HACCP, and BRCGS standards. Our Dutch regulatory team ensures that every batch meets the diverse standards of the EU, FDA, and Asian markets.
Q: Can you support startups with rapid prototyping?
A: Yes. We offer pilot-scale R&D services to help brands test formulations before full-scale manufacturing, significantly reducing time-to-market.
